Navigation Links
Mental illnesses are second leading cause of time off work in Spain

An interdisciplinary team coordinated by researchers from the University of Castilla La Mancha (UCLM) and the Canary Islands Health Service has evaluated the economic impact of mental illness in Spain, and estimated their social cost. According to the study, despite health resources being invested to alleviate the effects of such illnesses, informal care and lost work time places a heavy burden on society.

Mental illnesses affect a large number of people, impact on their quality of life and have high socioeconomic costs. "The three disease groups that the National Health System spends most on in Spain are cancer, circulatory system diseases and mental illnesses", Juan Oliva, lead author of the study and a researcher at the UCLM, tells SINC.

The study, published recently in the European Journal of Health Economics, shows that mental illnesses are the second leading cause of temporary and permanent sick leave, after osteomuscular complaints.

In addition, people suffering from mental illnesses are the fourth most likely to receive informal care (provided by non-professional carers, usually families), following those who have suffered strokes and heart attacks, dementia and osteomuscular disease.

The objective of the study was to estimate the socioeconomic impact of this kind of disease in Spain, based on data from 2002, the year with the greatest number of recorded sources. The latest figures, published on the Ministry of Health's website, are from 2006, but these are not broken down by disease type.

In addition to using normal units of evaluation, such as the number of premature deaths caused by mental disease, numbers of hospitalisations, doctor's visits and time off work, the team also included another indicator in their study direct non-medical costs, in other words the costs assumed by those caring for people who have lost their autonomy to some degree as a result of a mental illness.

Although Spain's autonomous region and central governments direct financial and human resources to the prevention and treatment of mental illnesses (as can be seen in estimated healthcare expenditure figures), "the hidden social cost (lost employment and the cost of informal care) represents an even bigger social burden", explains Oliva.

Other figures and percentages

The total cost of mental illnesses in Spain in 2002 has been estimated to be at least 7.019 billion, with direct medical costs accounting for 39.6% of this amount, representing at least 7.3% of total public healthcare costs in Spain that year.

According to the research, direct costs resulting from mental illnesses represented 57.3% of the total estimated cost, with the remaining 42.7% representing the loss in workplace productivity.

In terms of direct medical costs, the most significant expenditure resulted from hospitalisations (19.1% of total estimated cost) and drugs (15.6% of total estimated cost). Overall, total expenditure in 2002 represented almost 1% of Spain's gross domestic product (GDP).


Contact: SINC
FECYT - Spanish Foundation for Science and Technology

Related medicine news :

1. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
2. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
7. How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
8. Experimental Antidepressants Offer Faster Relief
9. Environmental stress probed in cardiovascular disease, diabetes
10. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
11. Mental Health Woes Strike Half of Cancer Patients
Post Your Comments:
Related Image:
Mental illnesses are second leading cause of time off work in Spain
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... has selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s ... including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica ...
(Date:12/1/2015)... ... 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has ... The order will be from the China Disabled Persons’ Federation, a central government association, ... solution for children and adults suffering from severe and profound hearing loss . ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced ... (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the training ... solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... UPPSALA, Sverige, December 1, 2015 ... Breast Cancer Study Group (IBCSG, Bern ... att ingå i en klinisk studie av palbociclib, ... --> Studien, med namn PYTHIA, ... med anti-hormonella läkemedel i kombination med palbociclib, som ...
(Date:11/30/2015)... MAPLE GROVE, Minn. and BASEL, ... Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned ... for the further development of a novel, oral small ... cell-adhesion molecule that may be effective in the treatment ... Phase II clinical development. --> ...
(Date:11/30/2015)... Dec. 1, 2015 Express Scripts (NASDAQ: ESRX ... IMMY ) to drive access to a low-cost alternative ... of toxoplasmosis that has been recently priced out of reach ... immune systems. --> --> ... leucovorin (a form of folic acid) for $1 per capsule for ...
Breaking Medicine Technology: